HNW
DGX icon

High Note Wealth’s Quest Diagnostics DGX Stock Holding History

High Note Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.05K Buy
38
+7
+23% +$1.37K ﹤0.01% 459
2026
Q1 		$6.08K Hold
31
– – ﹤0.01% 478
2025
Q4 		$5.38K Hold
31
– – ﹤0.01% 470
2025
Q3 		$5.91K Hold
31
– – ﹤0.01% 401
2025
Q2 		$5.57K Hold
31
– – ﹤0.01% 385
2025
Q1 		$5.25K Hold
31
– – ﹤0.01% 393
2024
Q4 		$4.68K Buy
+31
New +$4.82K ﹤0.01% 462

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

High Note Wealth's DGX Position: Q2 2026 in Review

High Note Wealth increased its Quest Diagnostics (DGX) stake by 23% in Q2 2026, buying an estimated $1.37K and bringing the position to 38 shares worth $8.05K. The position accounts for ﹤0.01% of the portfolio, ranked #459.

High Note Wealth first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • High Note Wealth held 38 shares of Quest Diagnostics worth $8.05K as of Q2 2026.
  • High Note Wealth bought 7 Quest Diagnostics shares in Q2 2026, an estimated $1.37K.
  • Quest Diagnostics made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #459 holding.
  • High Note Wealth first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.